Title : Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel.

Pub. Date : 2017 Feb

PMID : 26891871






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel. Clopidogrel cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 The aim of this study was to evaluate the influence of CYP3A4*1G (IVS10+12G>A, rs2242480) on the pharmacokinetics and pharmacodynamics of clopidogrel. Clopidogrel cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 METHODS: CYP3A4*1G polymorphism was determined in a group of 82 patients undergoing percutaneous coronary intervention and taking 75 mg of clopidogrel daily. Clopidogrel cytochrome P450 family 3 subfamily A member 4 Homo sapiens